Moffitt Cancer Center
Tampa, Florida, 33612, United States
Location contact
Christine Vinci, PhD
PRINCIPAL_INVESTIGATOR
Joseph Pidala, MD, PhD
SUB_INVESTIGATOR
Steve Sutton, PhD
SUB_INVESTIGATOR
Not Yet Recruiting
NCT Number: NCT07352943
Development of a Mindfulness-Based Smartphone Application for BMT Caregivers
This pilot study evaluates the feasibility, acceptability, usability, and engagement of a smartphone-delivered mindfulness intervention for caregivers of hematopoietic stem cell transplant (HCT) patients. Thirty caregivers will use the app for six weeks beginning the week prior to the patient's transplant. Participants will complete baseline and end-of-treatment surveys and a brief qualitative interview.
Not Yet Recruiting
Trial opening soon.
Get NotifiedKey information
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Age ≥18
- Identified caregiver of a patient scheduled for HCT at Moffitt Cancer Center
- Able to provide informed consent
- Able to read and write in English
- Owns a smartphone and willing to download the study app
Exclusion criteria
- None beyond failure to meet inclusion criteria
Treatment and study plan
App
BehavioralA smartphone-delivered mindfulness program providing daily modules, guided meditations, brief strategies, and reflection prompts designed to reduce caregiver burden and distress.
Primary outcomes
-
Feasibility: Recruitment Rate
Time frame: During the enrollment period (anticipated 6-8 months)
Recruitment will be assessed by the ability to recruit approximately 4 caregivers per month until the target sample of 30 is reached.
-
Feasibility: Retention Rate
Time frame: Baseline to 6 weeks
Percentage of enrolled participants who complete the study through the end-of-treatment.
-
Feasibility: Survey Completion
Time frame: Baseline and 6 weeks
Percentage of participants who complete the baseline REDCap survey and the end-of-treatment survey.
-
Acceptability: System Usability Scale (SUS)
Time frame: 6 weeks
Usability of the app measured using the System Usability Scale.
-
Engagement: Module Completion Rate
Time frame: 6 weeks
Number of modules completed per week.
Study contacts
Contact information is provided by the study sponsor or research team.
Sponsors and collaborators
Lead sponsor
H. Lee Moffitt Cancer Center and Research Institute
Other
Collaborators
- American Cancer Society, Inc.
Registry information
Important dates
- Study start
- 2026
- Primary completion
- 2026
- Study completion
- 2026
- First posted
- Jan 20, 2026
- Registry last updated
- Jan 20, 2026
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.